Cipla to acquire Inzpera Healthsciences

04 Nov 2025 Evaluate

Cipla has entered into definitive agreements to acquire 100% stake in Inzpera Healthsciences (Inzpera). The company will pay a consideration of around Rs 110.65 crore for acquisition of equity shares and non-convertible redeemable preference shares, representing 100% of Inzpera’s shareholding.

Upon acquisition, Inzpera will become wholly owned subsidiary of the company. The acquisition is a strategic move aimed at combining Inzpera’s extensive portfolio of paediatric pharmaceutical and wellness products with the company’s strong distribution network and operational capabilities to drive growth and scalability.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients.

Cipla Share Price

1525.60 4.40 (0.29%)
05-Dec-2025 14:10 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1806.80
Dr. Reddys Lab 1275.10
Cipla 1525.60
Zydus Lifesciences 933.55
Lupin 2101.20
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×